Respiratory Syncytial Virus (RSV) is showing an unusual surge this spring, prompting most states to prolong the immunization period for eligible infants and toddlers. RSV primarily leads to cold-like symptoms but can result in severe illnesses for young children.
RSV Surge Continues, States Extend Immunization Period
The RSV season generally commences in the fall, peaks during winter, and tapers off in spring. Traditionally, the immunization window is recommended until March. However, this year, nearly all states have extended the immunization period through April.
Current RSV Statistics
- 7.5% positivity rate for RSV tests as of mid-March.
- Comparison: 5% positivity rate during the same period last year.
- Two to three out of every 100 infants under three months are hospitalized annually due to RSV.
- Tens of thousands of children have been hospitalized this season alone.
Dr. Susan Kansagra, Chief Medical Officer for the Association of State and Territorial Health Officials, stated that the RSV season peaked later than usual. She noted that healthcare providers are extending the use of monoclonal antibodies to help prevent hospitalizations among infants.
Importance of Immunization
The American Academy of Pediatrics advocates for the use of monoclonal antibodies to prevent infections in infants and young children. A vaccine is also available for pregnant women. Monoclonal antibodies are designed to offer more passive immunity compared to vaccines, proving effective in reducing hospitalization rates associated with RSV.
Data from a recent CDC study revealed that RSV-related hospitalizations in infants up to seven months old during the 2024-25 season were lower due to these immunizations. This is the third season that monoclonal antibodies have been accessible for RSV protection.
Ongoing Surveillance and Recommendations
The CDC urged states to evaluate their local RSV data, leading to significant extensions in immunization periods. As of mid-March, 48 jurisdictions have extended their RSV season until at least April 30. This extension permits states to order immunizations through the federal Vaccines for Children program.
Dr. Tao Sheng Kwan-Gett from Washington State emphasized the goal of reducing hospitalizations by prolonging the immunization period in light of ongoing virus activity.
Variability of RSV Seasons
Experts are still investigating the reasons behind this season’s shift. Factors such as environmental conditions, behavioral patterns, and vaccine uptake may all play a role. Dr. Jennifer Nuzzo, an epidemiologist, stressed the importance of aligning public health responses with actual disease trends.
- Ten jurisdictions, such as Florida and Hawaii, maintain year-round RSV seasons.
- Louisiana and Washington, D.C., have chosen not to extend the immunization period.
- Missouri and Virginia will evaluate requests from providers individually.
In conclusion, the ongoing RSV surge has led to an unprecedented extension of the immunization period in many states. Experts urge continued vigilance to protect vulnerable infants as RSV remains a significant health concern.
